U.S. stocks on Friday afternoon within a narrow range, between the major indexes continued consolidation in the small ups and downs. Pharmaceutical sector are declining. But the technology companies supporting the strong earnings fell sharply tape Buzhi Yu.
EST at 12:56 on December 17 (Beijing time at 1:56 on December 18), the Dow Jones Industrial Average fell 24.52 points to 11,474.73 points, down 0.21%; the Nasdaq composite index rose 7.62 points to 2,644.93 points, or 0.29%; Standard & Poor's 500 index fell 0.17 points to 1,242.70 points, down 0.01%.
Pharmaceutical stocks were mostly lower, Dow component Merck (MRK) fell 1.8%, Pfizer (PFE) fell 1.1%. Pharmaceutical stocks fell across the board for a reason. U.S. Food and Drug Administration (FDA) yesterday recommended not to use under certain circumstances Roche (Roche Holding AG) of the breast cancer drug; today to delay approval of AstraZeneca (AZN) the company's blood-thinning drugs. In this case, the market worried that FDA may increase the threshold for regulation of pharmaceutical companies.
So far this week, the Dow rose 0.6%. Despite the end of the stock market is expected to be as many on Wall Street prepared to spend the holiday will not be large fluctuations, and the volume will be very light, but recent U.S. economic data released by the U.S. economic outlook that investors see the hope of gradually improving.
30 yr fixed mortgage rates
interest only loans
interest only loans rates
interest only mortgage rates
quantitative easing
china inflation
china inflation rate